Literature DB >> 31953539

The identification of novel mutations in PLCZ1 responsible for human fertilization failure and a therapeutic intervention by artificial oocyte activation.

Jian Mu1, Zhihua Zhang1, Ling Wu2, Jing Fu3, Biaobang Chen1, Zheng Yan2, Bin Li2, Zhou Zhou1, Wenjing Wang1, Lin Zhao1, Jie Dong1, Yanping Kuang2, Xiaoxi Sun3, Lin He4, Lei Wang1,5,6, Qing Sang1,5.   

Abstract

Fertilization involves a series of molecular events immediately following egg-sperm fusion; Ca2+ oscillations are the earliest signaling event, and they initiate the downstream reactions including pronucleus formation. Successful human reproduction requires normal fertilization. In clinical IVF or ICSI attempts, some infertile couples suffer from recurrent fertilization failure. However, the genetic reasons for fertilization failure are largely unknown. Here, we recruited several couples diagnosed with fertilization failure even though their gametes are morphologically normal. Through whole-exome sequencing and Sanger sequencing, we identified biallelic mutations in gene-encoding phospholipase C zeta 1 (PLCZ1) in four independent males in couples diagnosed with fertilization failure. Western blotting showed that missense mutations decreased the level of PLCZ1 and that nonsense or frameshift mutations resulted in undetectable or truncated proteins. Expression of these mutations in mice significantly reduced the levels of oocyte activation. Artificial oocyte activation in patient oocytes could rescue the phenotype of fertilization failure and help establish pregnancy and lead to live birth. Our findings expand the spectrum of PLCZ1 mutations that are responsible for human fertilization failure and provide a potentially feasible therapeutic treatment for these patients.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 PLCZ1 mutations; ART; ICSI; artificial oocyte activation; fertilization failure; sperm

Mesh:

Substances:

Year:  2020        PMID: 31953539     DOI: 10.1093/molehr/gaaa003

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  6 in total

1.  Microfluidic chips as a method for sperm selection improve fertilization rate in couples with fertilization failure.

Authors:  Jamileh Sadat Mirsanei; Nadia Sheibak; Zahra Zandieh; Mehdi Mehdizadeh; Reza Aflatoonian; Maryamsadat Tabatabaei; Atieh Sadat Mousavi; Fatemehsadat Amjadi
Journal:  Arch Gynecol Obstet       Date:  2022-06-02       Impact factor: 2.493

2.  Target-Sequencing of Female Infertility Pathogenic Gene Panel and a Novel TUBB8 Loss-of-Function Mutation.

Authors:  Hongxia Yuan; Jianhua Chen; Na Li; Hui Miao; Yao Chen; Shuyan Lyu; Yu Qiao; Guangping Yang; Hui Luo; Liangliang Chen; Fei Mao; Lingli Huang; Yanni He; Saifei Hu; Congxiu Miao; Yun Qian; Ruizhi Feng
Journal:  Front Genet       Date:  2022-05-10       Impact factor: 4.772

3.  Homozygous Loss of Septin12, but not its Haploinsufficiency, Leads to Male Infertility and Fertilization Failure.

Authors:  Haixia Chen; Peng Li; Xiaoling Du; Yiding Zhao; Lingling Wang; Ye Tian; Xueru Song; Ling Shuai; Xiaohong Bai; Lingyi Chen
Journal:  Front Cell Dev Biol       Date:  2022-04-25

Review 4.  Increasing associations between defects in phospholipase C zeta and conditions of male infertility: not just ICSI failure?

Authors:  Junaid Kashir
Journal:  J Assist Reprod Genet       Date:  2020-04-14       Impact factor: 3.412

5.  Homozygous pathogenic variants in ACTL9 cause fertilization failure and male infertility in humans and mice.

Authors:  Jing Dai; Tianlei Zhang; Jing Guo; Qinwei Zhou; Yifan Gu; Jue Zhang; Liang Hu; Yurong Zong; Juan Song; Shuoping Zhang; Can Dai; Fei Gong; Guangxiu Lu; Wei Zheng; Ge Lin
Journal:  Am J Hum Genet       Date:  2021-02-23       Impact factor: 11.025

Review 6.  SPERM FACTORS AND EGG ACTIVATION: Phospholipase C zeta (PLCZ1) and the clinical diagnosis of oocyte activation deficiency.

Authors:  C Jones; X Meng; K Coward
Journal:  Reproduction       Date:  2022-05-23       Impact factor: 3.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.